|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| A S S E T S | |||||
| Cash and due from banks | |||||
| Federal funds sold | |||||
| Cash and cash equivalents | |||||
| Fair Value, Total | |||||
| Federal Home Loan Bank stock, at cost | |||||
| Mortgage loans held for sale | |||||
| Loans, net of allowance for credit losses of $14,789 and $14,992, respectively | |||||
| Bank-owned life insurance | |||||
| Foreclosed assets, net | |||||
| Bank premises and equipment, net | |||||
| Goodwill and other intangibles | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Total assets | |||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||
| Liabilities: | |||||
| Noninterest-bearing | |||||
| Interest-bearing | |||||
| Total deposits | |||||
| Federal Home Loan Bank advances and other borrowings | |||||
| Securities sold under agreements to repurchase | |||||
| Dividends payable | |||||
| Accrued interest payable and other liabilities | |||||
| Subordinated debt, net of debt issuance costs of $129 and $146, respectively | |||||
| Total liabilities | |||||
| Stockholders’ equity: | |||||
| Common stock, $1 par value; 5,000,000 shares authorized; 2,388,748 and 2,375,138 shares issued and outstanding, respectively | |||||
| Additional paid-in-capital | |||||
| Retained earnings | |||||
| Accumulated other comprehensive loss | |||||
| Total stockholders’ equity | |||||
| Total liabilities and stockholders’ equity |
Loading...
